Achilles Therapeutics PLC Price Prediction
| ACHLDelisted Stock | USD 1.48 0.01 0.68% |
Momentum 69
Buy Stretched
Oversold | Overbought |
Using Achilles Therapeutics hype-based prediction, you can estimate the value of Achilles Therapeutics PLC from the perspective of Achilles Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Achilles Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Achilles because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Achilles Therapeutics after-hype prediction price | USD 1.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Achilles |
Achilles Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Achilles Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Achilles Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Achilles Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Achilles Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Achilles Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Achilles Therapeutics' historical news coverage. Achilles Therapeutics' after-hype downside and upside margins for the prediction period are 0.07 and 4.54, respectively. We have considered Achilles Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Achilles Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Achilles Therapeutics PLC is based on 3 months time horizon.
Achilles Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Achilles Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Achilles Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Achilles Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.48 | 3.06 | 0.00 | 0.14 | 3 Events / Month | 4 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.48 | 1.48 | 0.00 |
|
Achilles Therapeutics Hype Timeline
Achilles Therapeutics PLC is presently traded for 1.48. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.14. Achilles is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.48%. %. The volatility of related hype on Achilles Therapeutics is about 1015.17%, with the expected price after the next announcement by competition of 1.34. About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Achilles Therapeutics PLC recorded a loss per share of 1.66. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Achilles Therapeutics Basic Forecasting Models to cross-verify your projections.Achilles Therapeutics Related Hype Analysis
Having access to credible news sources related to Achilles Therapeutics' direct competition is more important than ever and may enhance your ability to predict Achilles Therapeutics' future price movements. Getting to know how Achilles Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Achilles Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASMB | Assembly Biosciences | 0.56 | 6 per month | 0.00 | (0.09) | 6.63 | (5.05) | 24.82 | |
| SPRO | Spero Therapeutics | (0.01) | 8 per month | 0.00 | (0.07) | 5.13 | (6.25) | 21.98 | |
| TIL | Instil Bio | (2.64) | 5 per month | 0.00 | (0) | 13.25 | (9.64) | 34.30 | |
| NLTX | Neoleukin Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NUVB | Nuvation Bio | (0.01) | 8 per month | 0.00 | (0.06) | 6.88 | (7.38) | 28.03 | |
| CTMX | CytomX Therapeutics | 0.00 | 9 per month | 0.00 | (0.13) | 7.32 | (7.45) | 17.13 | |
| NXTC | NextCure | (0.01) | 4 per month | 0.00 | (0.18) | 6.49 | (7.25) | 21.57 |
Achilles Therapeutics Additional Predictive Modules
Most predictive techniques to examine Achilles price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Achilles using various technical indicators. When you analyze Achilles charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Achilles Therapeutics Predictive Indicators
The successful prediction of Achilles Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Achilles Therapeutics PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Achilles Therapeutics based on analysis of Achilles Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Achilles Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Achilles Therapeutics's related companies.
Story Coverage note for Achilles Therapeutics
The number of cover stories for Achilles Therapeutics depends on current market conditions and Achilles Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Achilles Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Achilles Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Achilles Therapeutics Short Properties
Achilles Therapeutics' future price predictability will typically decrease when Achilles Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Achilles Therapeutics PLC often depends not only on the future outlook of the potential Achilles Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Achilles Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40 M | |
| Cash And Short Term Investments | 131.5 M |
Check out Achilles Therapeutics Basic Forecasting Models to cross-verify your projections. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |